A report on the largest multistate produce-linked Shiga toxin-producing Escherichia coli outbreak in the United States highlighted challenges in determining the route of contaminated lettuce and in providing rapid, actionable guidance during an outbreak.
Data gathered from a meta-analysis of clinical practice guidelines published in the European Journal of Clinical Microbiology and Infectious Diseases, show that well-designed randomized controlled trials are urgently needed.
Only one in four patients with sinonasal squamous cell carcinoma is tested for human papillomavirus.
Researchers assessed the diagnostic value of clinical factors as well as biochemical or microbiologic measures for diagnosis of drain-associated ventriculitis.
The Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) have updated consensus definitions of invasive fungal diseases.
Study authors highlighted that while diagnostic associations are helpful in suggesting diagnostic possibilities, they must be supported by clinical correlation of characteristic clinical features.
Failure to adopt updated antimicrobial susceptibility testing breakpoints may lead to reports of false susceptibility for antimicrobials commonly used to treat Gram-negative infections and preclude recognition of CRE.
The FDA has launched CURE ID, an internet-based repository that allows clinicians to report their experiences using existing FDA-approved drugs for difficult-to-treat infections.
The FDA has authorized marketing of a new diagnostic test, cobas vivoDx MRSA, to detect MRSA bacterial colonization.
A digital sepsis alert presents opportunity to improve care for patients who may have sepsis.
